These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22451516)

  • 1. The type II secretion system and its ubiquitous lipoprotein substrate, SslE, are required for biofilm formation and virulence of enteropathogenic Escherichia coli.
    Baldi DL; Higginson EE; Hocking DM; Praszkier J; Cavaliere R; James CE; Bennett-Wood V; Azzopardi KI; Turnbull L; Lithgow T; Robins-Browne RM; Whitchurch CB; Tauschek M
    Infect Immun; 2012 Jun; 80(6):2042-52. PubMed ID: 22451516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissection of the role of pili and type 2 and 3 secretion systems in adherence and biofilm formation of an atypical enteropathogenic Escherichia coli strain.
    Hernandes RT; De la Cruz MA; Yamamoto D; Girón JA; Gomes TA
    Infect Immun; 2013 Oct; 81(10):3793-802. PubMed ID: 23897608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.
    Berger CN; Crepin VF; Baruch K; Mousnier A; Rosenshine I; Frankel G
    mBio; 2012; 3(5):. PubMed ID: 23033475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections.
    Zurawski DV; Mumy KL; Badea L; Prentice JA; Hartland EL; McCormick BA; Maurelli AT
    Infect Immun; 2008 Jan; 76(1):369-79. PubMed ID: 17984206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection.
    Serapio-Palacios A; Finlay BB
    Curr Opin Microbiol; 2020 Apr; 54():67-76. PubMed ID: 32058947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YghG (GspSβ) is a novel pilot protein required for localization of the GspSβ type II secretion system secretin of enterotoxigenic Escherichia coli.
    Strozen TG; Li G; Howard SP
    Infect Immun; 2012 Aug; 80(8):2608-22. PubMed ID: 22585966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tandem tyrosine phosphosites in the Enteropathogenic Escherichia coli chaperone CesT are required for differential type III effector translocation and virulence.
    Runte CS; Jain U; Getz LJ; Secord S; Kuwae A; Abe A; LeBlanc JJ; Stadnyk AW; Kaper JB; Hansen AM; Thomas NA
    Mol Microbiol; 2018 Jun; 108(5):536-550. PubMed ID: 29509331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The non-pathogenic Escherichia coli strain W secretes SslE via the virulence-associated type II secretion system beta.
    Decanio MS; Landick R; Haft RJ
    BMC Microbiol; 2013 Jun; 13():130. PubMed ID: 23758679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic relatedness and virulence properties of enteropathogenic Escherichia coli strains of serotype O119:H6 expressing localized adherence or localized and aggregative adherence-like patterns on HeLa cells.
    Garcia BG; Ooka T; Gotoh Y; Vieira MA; Yamamoto D; Ogura Y; Girão DM; Sampaio SC; Melo AB; Irino K; Hayashi T; Gomes TA
    Int J Med Microbiol; 2016 May; 306(3):152-64. PubMed ID: 27083266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic role of curli and cellulose in cell adherence and biofilm formation of attaching and effacing Escherichia coli and identification of Fis as a negative regulator of curli.
    Saldaña Z; Xicohtencatl-Cortes J; Avelino F; Phillips AD; Kaper JB; Puente JL; Girón JA
    Environ Microbiol; 2009 Apr; 11(4):992-1006. PubMed ID: 19187284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GELFrEE fractionation combined with mass spectrometry for proteome analysis of secreted toxins from Enteropathogenic Escherichia coli (EPEC).
    Orton DJ; Arsenault DJ; Thomas NA; Doucette AA
    Mol Cell Probes; 2013; 27(5-6):200-7. PubMed ID: 23831145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strains.
    Nesta B; Valeri M; Spagnuolo A; Rosini R; Mora M; Donato P; Alteri CJ; Del Vecchio M; Buccato S; Pezzicoli A; Bertoldi I; Buzzigoli L; Tuscano G; Falduto M; Rippa V; Ashhab Y; Bensi G; Fontana MR; Seib KL; Mobley HL; Pizza M; Soriani M; Serino L
    PLoS Pathog; 2014 May; 10(5):e1004124. PubMed ID: 24809621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and genotypic characteristics associated with biofilm formation in clinical isolates of atypical enteropathogenic Escherichia coli (aEPEC) strains.
    Nascimento HH; Silva LE; Souza RT; Silva NP; Scaletsky IC
    BMC Microbiol; 2014 Jul; 14():184. PubMed ID: 25012525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of Type III Secretion System Effector/Chaperone Ratio Fosters Pathogen Adaptation to Host-Adherent Lifestyle.
    Elbaz N; Socol Y; Katsowich N; Rosenshine I
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient shielding of intimin and the type III secretion system of enterohemorrhagic and enteropathogenic Escherichia coli by a group 4 capsule.
    Shifrin Y; Peleg A; Ilan O; Nadler C; Kobi S; Baruch K; Yerushalmi G; Berdichevsky T; Altuvia S; Elgrably-Weiss M; Abe C; Knutton S; Sasakawa C; Ritchie JM; Waldor MK; Rosenshine I
    J Bacteriol; 2008 Jul; 190(14):5063-74. PubMed ID: 18502854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a restriction minus enteropathogenic Escherichia coli E2348/69 strain that is efficiently transformed with large, low copy plasmids.
    Hobson N; Price NL; Ward JD; Raivio TL
    BMC Microbiol; 2008 Aug; 8():134. PubMed ID: 18681975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Regulation of the Surface-Exposed and Secreted SslE Lipoprotein in Extraintestinal Pathogenic Escherichia coli.
    Tan L; Moriel DG; Totsika M; Beatson SA; Schembri MA
    PLoS One; 2016; 11(9):e0162391. PubMed ID: 27598999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Characterization of EscK (Orf4), a Sorting Platform Component of the Enteropathogenic Escherichia coli Injectisome.
    Soto E; Espinosa N; Díaz-Guerrero M; Gaytán MO; Puente JL; González-Pedrajo B
    J Bacteriol; 2017 Jan; 199(1):. PubMed ID: 27795324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis and Functional Analysis of the Bacterial Arginine Glycosyltransferase Effector NleB1 from Enteropathogenic Escherichia coli.
    Wong Fok Lung T; Giogha C; Creuzburg K; Ong SY; Pollock GL; Zhang Y; Fung KY; Pearson JS; Hartland EL
    Infect Immun; 2016 May; 84(5):1346-1360. PubMed ID: 26883593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli.
    Thanabalasuriar A; Koutsouris A; Weflen A; Mimee M; Hecht G; Gruenheid S
    Cell Microbiol; 2010 Jan; 12(1):31-41. PubMed ID: 19712078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.